ZTS
TYPE Stocks
GROUP Stocks
BASE ZTS
SECOND US Dollar
<% (signals.list.current.rate).substr(0,7) %>
<% (signals.list.current.absolute).substr(0,9) %> (<% signals.list.current.percentage|toFixed:2 %>%)
MARKETS TREND
OPEN
<% (signals.list.current.openrate).substr(0,9) %>
HIGH
<% (signals.list.current.high).substr(0,9) %>
LOW
<% (signals.list.current.low).substr(0,9) %>
ZTS Signals
DON'T WANT TO MISS ANY SIGNAL? GO PREMIUM
ACCESS ALL FX, COMMODITIES & CRYPTO SIGNALS. GO PREMIUM
<% signal.pair %> (<% signal.rate %>) <% signal.action %>
<% signal.status %>
<% signal.analyst %><% signal.analyst %>
Long Term
Entry Price
Stop Loss
Take Profit
PREMIUM ONLY
<% signal.stopLoss %> N/A
PREMIUM ONLY
<% signal.takeProfit %> N/A
PREMIUM ONLY
<% signal.analyst %><% signal.analyst %>
<% signal.comment %>
Description
<% signal.description %>
LATEST ANALYSIS
<% item.time_ago %> Ago
<% item.title %>
<% item.deltaTime %>

ZTS Signals & Technical Analysis

Last Updated: <% indicators.interval.updated|date:'MMM d, y h:mm:ss a' %>
Market Trend
Strong Sell
Sell
Neutral
Buy
Strong Buy
Loading Market Trend ...

Market Sentiment

BUY: <% indicators.sentiment.buy.length %> SELL: <% indicators.sentiment.sell.length %> NEUTRAL: <% indicators.sentiment.neutral.length %>
Strong Sell
Sell
Neutral
Buy
Strong Buy

Trend Indicators

NAME
VALUE
ACTION
Bollinger Bands
UPPER: <% indicators.data[indicators.interval.active].bbands.value.upper %>
MIDDLE: <% indicators.data[indicators.interval.active].bbands.value.middle %>
LOWER: <% indicators.data[indicators.interval.active].bbands.value.lower %>
Sell
Buy
Parabolic SAR
<% indicators.data[indicators.interval.active].sar.value %>
Sell
Buy
Standard Deviation
<% indicators.data[indicators.interval.active].stddev.value %>
High Volatility
Low Volatility

Oscillators

NAME
VALUE
ACTION
RSI(14)
<% indicators.data[indicators.interval.active].rsi.value %>
Sell
Buy
MACD(12,26)
<% indicators.data[indicators.interval.active].macd.value %>
Buy
Sell
Neutral
ATR
<% indicators.data[indicators.interval.active].atr.value %>
High Volatility
Low Volatility
STOCH(9,6)
<% indicators.data[indicators.interval.active].stochastics.value %>
Buy
Sell
ADX
<% indicators.data[indicators.interval.active].adx.value %>
High Volatility
Low Volatility

Moving Averages

PERIOD
SIMPLE
EXPONENTIAL
MA5
<% indicators.data[indicators.interval.active].sma5.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema5.value %> Buy Sell
MA10
<% indicators.data[indicators.interval.active].sma10.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema10.value %> Buy Sell
MA20
<% indicators.data[indicators.interval.active].sma20.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema20.value %> Buy Sell
MA50
<% indicators.data[indicators.interval.active].sma50.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema50.value %> Buy Sell
MA100
<% indicators.data[indicators.interval.active].sma100.value %> Buy Sell
<% indicators.data[indicators.interval.active].ema100.value %> Buy Sell

Pivot

PIVOT
CLASSIC
FIBONACCI
CAMARILLA
WOODIE
S3
<% indicators.data[indicators.interval.active].pp.data.result.classic.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s3 %>
S2
<% indicators.data[indicators.interval.active].pp.data.result.classic.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s2 %>
S1
<% indicators.data[indicators.interval.active].pp.data.result.classic.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.s1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.s1 %>
PP
<% indicators.data[indicators.interval.active].pp.data.result.classic.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.pp %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.pp %>
R1
<% indicators.data[indicators.interval.active].pp.data.result.classic.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r1 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r1 %>
R2
<% indicators.data[indicators.interval.active].pp.data.result.classic.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r2 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r2 %>
R3
<% indicators.data[indicators.interval.active].pp.data.result.classic.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.fibonacci.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.camarilla.r3 %>
<% indicators.data[indicators.interval.active].pp.data.result.woodie.r3 %>

About (ZTS) Zoetis Inc.

Company Background

Zoetis Inc. (NYSE: ZTS) is a leading global animal health company headquartered in Parsippany, New Jersey, United States. Founded in 1952 as a subsidiary of the pharmaceutical giant IDEXX Laboratories, Zoetis became an independent entity in 2013. The company specializes in the discovery, development, and production of veterinary vaccines and medicines for both companion animals and livestock.

Market Position

As one of the largest players in the animal health sector, Zoetis holds a significant market share, supported by a diverse portfolio of products, which includes vaccines, dermatology solutions, anesthesia, and anti-infectives. The company operates in over 100 countries worldwide and serves veterinarians, farmers, and animal producers. With a strong commitment to innovation, Zoetis invests heavily in research and development, aiming to provide cutting-edge solutions that enhance animal health and productivity.

Key Financial Highlights

In 2022, Zoetis reported revenues of approximately $7.8 billion, reflecting steady growth driven by increased demand for pet care products and livestock health solutions. The company has consistently demonstrated strong financial performance, boasting a healthy operating margin and a commitment to returning value to shareholders through dividends and strategic acquisitions. As of the latest reports, Zoetis maintains a robust balance sheet with a strong cash flow, enabling continued investment in research and strategic growth initiatives.

Industry Highlights

The global animal health market is projected to experience substantial growth, driven by trends such as increased pet ownership, a rising focus on food safety, and advancements in veterinary medicine. Zoetis is well-positioned to capitalize on these trends, leveraging its extensive research capabilities and innovative product offerings. The company's strategic initiatives aim to expand its presence in emerging markets and enhance its product pipeline, ensuring sustained growth and market leadership in the dynamic animal health industry.

Related Stocks

RGC logo
RGC
Regencell Bioscience Holdings Ltd.
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
CGC logo
CGC
Canopy Growth Corporation
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
ACB logo
ACB
Aurora Cannabis Inc.
0
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ

HFM

Doo Prime

XM

Best Forex Brokers